Profound Bio
AcquiredWelcome to Genmab
Profound Bio is headquartered in Redmond, United States and has $237.0M in recorded funding across 3 rounds.
- Headquarters
- Redmond, Washington
- Business Model
- B2B
- Website
- profoundbio.com
- Total Funding
- $237.0M
- Last Round
- $112.0M Series BFeb 2024
- Rounds
- 3
- Acquired by
- Genmab A/SApr 2024 · $1.8B
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 10 investors for this company. The full record is or through the API.
About
Clinical-stage biotech developing antibody-drug conjugates; acquired by Genmab in 2024.
Summary
Profound Bio is a Biotech company based in Redmond, United States. It has raised $237.0M in total across 3 rounds, most recently a $112.0M Series B round in Feb 2024. Investors include Lilly Asia Ventures, Genmab and Ally Bridge Group.
Tech & App Stack
11 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Apr 2024
Sign up to see all 4 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/profound-bio"><img src="https://indexed.vc/api/badge/company/profound-bio" alt="Profound Bio on Indexed.vc" width="260" height="76" /></a>